David Darst joined OrbiMed in 2007 to identify and develop investments in biotechnology and medical device companies. Mr. Darst is a co-founder of two biotechnology companies, Potentia Pharmaceuticals and Medicine in Need, with treatments in development for Age-Related Macular Degeneration and Tuberculosis respectively. He also co-founded an internet health company, Firefly Health, and worked as a summer associate with McKinsey & Company, Pfizer, and Millennium Pharmaceuticals. Mr. Darst earned an A.B. degree cum laude from Harvard College and an M.B.A. from Harvard Business School. Mr. Darst is a founding investor of Good Start Genetics, serves on the board of Potentia Pharmaceuticals, is a board observer of ForteBio, and is active in OrbiMed's investments in Vivus (NASDAQ: VVUS) and Amarin (NASDAQ: AMRN).